AL
SCLN

Airain Ltd’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Airain Ltd’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,417
Closed -$131K – 1164
2017
Q1 		$131K Buy
+13,417
New +$134K 0.01% 743
2016
Q4 		– Sell
-17,905
Closed -$184K – 953
2016
Q3 		$184K Buy
+17,905
New +$195K 0.01% 536
2016
Q2 		– Sell
-18,566
Closed -$204K – 1039
2016
Q1 		$204K Buy
18,566
+6,236
+51% +$55.5K 0.01% 675
2015
Q4 		$113K Buy
+12,330
New +$103K 0.01% 757
2015
Q3 		– Sell
-15,635
Closed -$154K – 1192
2015
Q2 		$154K Sell
15,635
-17,582
-53% -$160K 0.01% 787
2015
Q1 		$294K Sell
33,217
-9,801
-23% -$78.1K 0.02% 639
2014
Q4 		$377K Buy
43,018
+4,385
+11% +$35.5K 0.03% 445
2014
Q3 		$266K Buy
+38,633
New +$232K 0.02% 613

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Airain Ltd's SCLN Position: Q2 2017 in Review

Airain Ltd sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2017, closing a stake of 13,417 shares — an estimated $131K sold.

Airain Ltd first reported a position in SCLN in Q3 2014 and held it in 8 quarters. The position peaked at $377K in Q4 2014. 142 funds tracked by Wall St. Rank hold SCLN as of Q2 2017.

  • Airain Ltd reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 13,417 Sciclone Pharmaceuticals Inc shares in Q2 2017, an estimated $131K.
  • Airain Ltd first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and held it in 8 quarters.
  • Airain Ltd's Sciclone Pharmaceuticals Inc position peaked at $377K in Q4 2014.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.